vs
Side-by-side financial comparison of AMPCO PITTSBURGH CORP (AP) and AVANOS MEDICAL, INC. (AVNS). Click either name above to swap in a different company.
AVANOS MEDICAL, INC. is the larger business by last-quarter revenue ($180.9M vs $104.4M, roughly 1.7× AMPCO PITTSBURGH CORP). AVANOS MEDICAL, INC. runs the higher net margin — -0.7% vs -55.2%, a 54.5% gap on every dollar of revenue. On growth, AMPCO PITTSBURGH CORP posted the faster year-over-year revenue change (11.5% vs 0.7%). AVANOS MEDICAL, INC. produced more free cash flow last quarter ($21.3M vs $-64.0K). Over the past eight quarters, AVANOS MEDICAL, INC.'s revenue compounded faster (4.4% CAGR vs -2.6%).
Ampco-Pittsburgh Corporation is a specialty steel manufacturer headquartered in Downtown Pittsburgh, Pennsylvania. It is one of several companies to bear the Ampco name, and it should not be confused with the Milwaukee-based copper base alloy producer, Ampco Metal Inc.; the Miami-based cabinetry company; the Swiss aluminum corporation; or the Dallas-based tool company. Ampco was formed in 1929 and is a conglomerate made up of several previously established small steel makers. Five small compa...
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
AP vs AVNS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $104.4M | $180.9M |
| Net Profit | $-57.7M | $-1.3M |
| Gross Margin | — | 47.5% |
| Operating Margin | -54.0% | 1.4% |
| Net Margin | -55.2% | -0.7% |
| Revenue YoY | 11.5% | 0.7% |
| Net Profit YoY | -1958.9% | 99.7% |
| EPS (diluted) | $-2.87 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $104.4M | $180.9M | ||
| Q3 25 | $103.7M | $177.8M | ||
| Q2 25 | $108.9M | $175.0M | ||
| Q1 25 | $99.2M | $167.5M | ||
| Q4 24 | $93.6M | $179.6M | ||
| Q3 24 | $92.1M | $170.4M | ||
| Q2 24 | $107.1M | $171.7M | ||
| Q1 24 | $110.0M | $166.1M |
| Q4 25 | $-57.7M | $-1.3M | ||
| Q3 25 | $-2.2M | $-1.4M | ||
| Q2 25 | $-7.3M | $-76.8M | ||
| Q1 25 | $1.1M | $6.6M | ||
| Q4 24 | $3.1M | $-397.3M | ||
| Q3 24 | $-2.0M | $4.3M | ||
| Q2 24 | $2.0M | $1.8M | ||
| Q1 24 | $-2.7M | $-900.0K |
| Q4 25 | — | 47.5% | ||
| Q3 25 | — | 48.4% | ||
| Q2 25 | — | 52.6% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 54.6% | ||
| Q3 24 | — | 54.5% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 57.1% |
| Q4 25 | -54.0% | 1.4% | ||
| Q3 25 | 1.1% | 0.1% | ||
| Q2 25 | -2.8% | -42.6% | ||
| Q1 25 | 3.9% | 6.1% | ||
| Q4 24 | 5.5% | -233.0% | ||
| Q3 24 | 2.0% | 7.0% | ||
| Q2 24 | 4.7% | 3.7% | ||
| Q1 24 | 0.1% | 2.4% |
| Q4 25 | -55.2% | -0.7% | ||
| Q3 25 | -2.1% | -0.8% | ||
| Q2 25 | -6.7% | -43.9% | ||
| Q1 25 | 1.2% | 3.9% | ||
| Q4 24 | 3.3% | -221.2% | ||
| Q3 24 | -2.1% | 2.5% | ||
| Q2 24 | 1.9% | 1.0% | ||
| Q1 24 | -2.5% | -0.5% |
| Q4 25 | $-2.87 | $-0.02 | ||
| Q3 25 | $-0.11 | $-0.03 | ||
| Q2 25 | $-0.36 | $-1.66 | ||
| Q1 25 | $0.06 | $0.14 | ||
| Q4 24 | $0.16 | $-8.64 | ||
| Q3 24 | $-0.10 | $0.09 | ||
| Q2 24 | $0.10 | $0.04 | ||
| Q1 24 | $-0.14 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.7M | $89.8M |
| Total DebtLower is stronger | $117.9M | $90.3M |
| Stockholders' EquityBook value | $32.6M | $778.2M |
| Total Assets | $495.4M | $1.1B |
| Debt / EquityLower = less leverage | 3.61× | 0.12× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.7M | $89.8M | ||
| Q3 25 | $15.0M | $70.5M | ||
| Q2 25 | $9.9M | $90.3M | ||
| Q1 25 | $7.1M | $97.0M | ||
| Q4 24 | $15.4M | $107.7M | ||
| Q3 24 | $11.8M | $89.0M | ||
| Q2 24 | $7.9M | $92.2M | ||
| Q1 24 | $10.8M | $75.8M |
| Q4 25 | $117.9M | $90.3M | ||
| Q3 25 | $119.0M | $93.4M | ||
| Q2 25 | $115.9M | $95.7M | ||
| Q1 25 | $115.0M | $98.0M | ||
| Q4 24 | $116.4M | $125.3M | ||
| Q3 24 | $116.0M | $152.6M | ||
| Q2 24 | $119.4M | $164.9M | ||
| Q1 24 | $116.2M | $167.2M |
| Q4 25 | $32.6M | $778.2M | ||
| Q3 25 | $60.1M | $778.0M | ||
| Q2 25 | $62.7M | $776.3M | ||
| Q1 25 | $64.6M | $839.4M | ||
| Q4 24 | $58.9M | $828.5M | ||
| Q3 24 | $61.3M | $1.2B | ||
| Q2 24 | $58.0M | $1.2B | ||
| Q1 24 | $56.3M | $1.2B |
| Q4 25 | $495.4M | $1.1B | ||
| Q3 25 | $524.4M | $1.1B | ||
| Q2 25 | $537.2M | $1.0B | ||
| Q1 25 | $536.2M | $1.1B | ||
| Q4 24 | $530.9M | $1.2B | ||
| Q3 24 | $547.4M | $1.7B | ||
| Q2 24 | $560.8M | $1.7B | ||
| Q1 24 | $565.8M | $1.7B |
| Q4 25 | 3.61× | 0.12× | ||
| Q3 25 | 1.98× | 0.12× | ||
| Q2 25 | 1.85× | 0.12× | ||
| Q1 25 | 1.78× | 0.12× | ||
| Q4 24 | 1.98× | 0.15× | ||
| Q3 24 | 1.89× | 0.12× | ||
| Q2 24 | 2.06× | 0.13× | ||
| Q1 24 | 2.06× | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.7M | $28.2M |
| Free Cash FlowOCF − Capex | $-64.0K | $21.3M |
| FCF MarginFCF / Revenue | -0.1% | 11.8% |
| Capex IntensityCapex / Revenue | 2.7% | 3.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.1M | $43.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.7M | $28.2M | ||
| Q3 25 | $6.3M | $14.0M | ||
| Q2 25 | $-2.3M | $6.8M | ||
| Q1 25 | $-5.3M | $25.7M | ||
| Q4 24 | $7.5M | $57.9M | ||
| Q3 24 | $11.4M | $23.0M | ||
| Q2 24 | $-5.3M | $27.8M | ||
| Q1 24 | $4.5M | $-8.0M |
| Q4 25 | $-64.0K | $21.3M | ||
| Q3 25 | $3.3M | $7.0M | ||
| Q2 25 | $-3.8M | $-4.2M | ||
| Q1 25 | $-7.5M | $19.0M | ||
| Q4 24 | $3.7M | $53.1M | ||
| Q3 24 | $8.4M | $20.0M | ||
| Q2 24 | $-8.0M | $21.9M | ||
| Q1 24 | $1.7M | $-12.1M |
| Q4 25 | -0.1% | 11.8% | ||
| Q3 25 | 3.2% | 3.9% | ||
| Q2 25 | -3.5% | -2.4% | ||
| Q1 25 | -7.5% | 11.3% | ||
| Q4 24 | 4.0% | 29.6% | ||
| Q3 24 | 9.1% | 11.7% | ||
| Q2 24 | -7.5% | 12.8% | ||
| Q1 24 | 1.5% | -7.3% |
| Q4 25 | 2.7% | 3.8% | ||
| Q3 25 | 2.9% | 3.9% | ||
| Q2 25 | 1.3% | 6.3% | ||
| Q1 25 | 2.2% | 4.0% | ||
| Q4 24 | 4.0% | 2.7% | ||
| Q3 24 | 3.2% | 1.8% | ||
| Q2 24 | 2.5% | 3.4% | ||
| Q1 24 | 2.6% | 2.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -4.62× | 3.89× | ||
| Q4 24 | 2.40× | — | ||
| Q3 24 | — | 5.35× | ||
| Q2 24 | -2.64× | 15.44× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AP
| Forged And Cast Mill Rolls | $67.0M | 64% |
| Air Handling Systems | $14.3M | 14% |
| Heat Exchange Coils | $13.1M | 13% |
| Centrifugal Pumps | $10.3M | 10% |
| Forged Engineered Products | $4.0M | 4% |
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
